Mounjaro on the NHS: Who Qualifies and How to Access It

Mounjaro on the NHS: Who Qualifies and How to Access It

Mounjaro (tirzepatide) is available on the NHS, but access is restricted to patients who meet specific clinical criteria and are referred through specialist weight management services. For the majority of adults in the UK looking to use Mounjaro for weight loss, a private prescription remains the most accessible and timely route. This guide explains the NHS pathway, who qualifies, what the criteria involve, and what your options are if you do not meet them.

Book Your Appointment

NICE Guidance: What Has Been Approved

Mounjaro has received two separate NICE technology appraisals covering its NHS use. The first, TA924 published in 2023, approved tirzepatide for the treatment of type 2 diabetes in adults alongside diet and exercise. The second, TA1026 published in 2024, recommended Mounjaro for chronic weight management in adults, but specifically within NHS specialist weight management services, not through standard GP prescribing.

This distinction matters. Even though Mounjaro is technically approved for weight management on the NHS, the pathway to accessing it is not a straightforward GP prescription. It requires referral into a tier 3 or tier 4 specialist weight management service, which are not uniformly available across all areas of England.

The full NICE guidance and eligibility criteria can be reviewed on the NICE website for TA1026.

mounjaro weight loss NHS

NHS Eligibility Criteria for Mounjaro (Weight Management)

Under TA1026, Mounjaro is recommended on the NHS for weight management in adults who meet all of the following conditions:

Criteria Requirement
BMI 35 kg/m² or above (lower thresholds apply for some ethnic groups)
Weight-related conditions At least one, such as type 2 diabetes, hypertension, or dyslipidaemia
Care setting Must be referred to a specialist NHS weight management service
Duration Treatment recommended for a maximum of 2 years under current guidance
Previous treatment Having engaged with behavioural and lifestyle interventions

Criteria are subject to change as NHS commissioning guidance develops. Always confirm current eligibility with your GP or specialist service.

How to Access Mounjaro on the NHS

The process for accessing Mounjaro through the NHS typically follows these steps:

    1. 1. Speak to your GP
      Discuss your weight, BMI, and any related health conditions. Your GP will assess whether you meet the threshold for referral and whether a specialist weight management service is available in your area.
    1. 2. Referral to a specialist service
      If eligible, your GP refers you to a tier 3 specialist weight management service. These services provide structured dietary, behavioural, and medical support. Not all areas have these services readily available, and waiting lists vary significantly by region.
    1. 3. Assessment at the specialist service
      The specialist team will conduct their own clinical assessment, confirm your suitability for Mounjaro, and oversee your treatment plan, including dose escalation and monitoring.
  1. 4. Prescription and dispensing
    If approved, Mounjaro is prescribed and dispensed as part of your specialist service programme. Treatment is reviewed at regular intervals and is currently recommended for a maximum of two years under NHS guidance.

Why Many Patients Choose Private Prescription Instead

The NHS pathway for Mounjaro, while available in principle, presents several practical barriers for many patients. Specialist weight management services are not evenly distributed across England, waiting times for referral and assessment can be lengthy, and the BMI threshold of 35 excludes a significant number of people who may still benefit clinically from treatment.

Private prescription services like our Mounjaro weight loss programme in Chelmsford offer an accessible alternative. Appointments are available throughout the week, there is no waiting list, and treatment can begin as soon as clinical suitability is confirmed. Private provision does not affect your NHS entitlements, and patients can always return to NHS pathways if their circumstances change.

Mounjaro on the NHS vs Private: Key Differences

Cost
NHS provision is free at the point of use for eligible patients. Private prescriptions are funded by the patient, with costs at Colecross Pharmacy starting from £179 per 4-week supply at the 2.5 mg starting dose.
Waiting times
NHS access requires GP referral and specialist assessment, which can take weeks to months, depending on local service capacity. Private appointments are typically available within days.
Eligibility
NHS criteria require a BMI of 35 or above with at least one weight-related condition. Private services assess eligibility on clinical grounds with no fixed BMI cutoff, though a full health assessment is still required.
Treatment duration
NHS guidance currently limits Mounjaro to two years. Private treatment duration is determined by your clinical team based on your ongoing progress and needs.

NHS weight loss injections

Frequently Asked Questions: Mounjaro on the NHS

Can my GP prescribe Mounjaro directly on the NHS?

Not currently for weight management. Under TA1026, Mounjaro for weight loss must be initiated within a specialist NHS weight management service, not through standard GP prescribing. Your GP can refer you to such a service if you meet the eligibility criteria. Mounjaro for type 2 diabetes under TA924 may be prescribed in primary care settings.

What BMI do I need for Mounjaro on the NHS?

The current NICE threshold is a BMI of 35 kg/m² or above, alongside at least one weight-related health condition. A lower BMI threshold may apply for people from South Asian, Chinese, Middle Eastern, Black African, or Black Caribbean backgrounds, where the health risks associated with excess weight occur at a lower BMI. Your GP or specialist team will confirm the applicable threshold for you.

Is Mounjaro available on the NHS in all parts of the UK?

Mounjaro has been approved by NICE for England. Scotland, Wales, and Northern Ireland have their own medicines approval processes through SMC, AWMSG, and the Northern Ireland formulary, respectively. Availability and commissioning decisions also vary by integrated care board within England, so local access is not guaranteed even where NICE guidance exists.

How long is the waiting list for NHS Mounjaro?

Waiting times for specialist weight management services vary significantly by region and local NHS capacity. In some areas, waits of six months or more have been reported. If waiting is not practical for your circumstances, a private service such as ours in Chelmsford offers a faster route to beginning treatment.

Will going private for Mounjaro affect my NHS treatment?

No. Accessing Mounjaro privately does not affect your entitlement to NHS care. You can still speak to your GP about your weight and related health conditions, and you remain eligible to be referred to NHS specialist services if you meet the criteria. Many patients use private services while waiting for NHS assessment or while below the NHS BMI threshold.

Find Out About Mounjaro at Colecross Pharmacy, Chelmsford

If you do not meet NHS eligibility criteria or would prefer not to wait, our clinical team at Colecross Pharmacy offers a fully supervised Mounjaro programme with appointments available throughout the week. Book your consultation today to find out whether private treatment is right for you.

Loading...

⚠ Important Disclaimer

This blog is intended as a general guide only and does not constitute personalised medical advice. Individual responses to Mounjaro can vary, and this information should not replace a consultation with a qualified healthcare professional. If you have specific concerns about side effects or your suitability for treatment, please get in touch with our team or speak to your GP.

☑ Clinically Reviewed by Pharmacy Mentor
A pharmacist reviews the content to help ensure medicines are presented responsibly and that patient-facing health information is accurate, appropriate, and aligned with current clinical guidance.
Last reviewed: 27 July 2026
Written on behalf of Colecross Pharmacy by Pharmacy Mentor.